Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Share-based Compensation (2019 - 2025)

Historic Share-based Compensation for Bioadaptives (BDPT) over the last 5 years, with Q3 2025 value amounting to $105000.0.

  • Bioadaptives' Share-based Compensation changed N/A to $105000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $547541.0, marking a year-over-year change of. This contributed to the annual value of $208871.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Bioadaptives' Share-based Compensation stood at $105000.0.
  • Over the past 5 years, Bioadaptives' Share-based Compensation peaked at $208871.0 during Q4 2024, and registered a low of $90000.0 during Q1 2025.
  • Moreover, its 3-year median value for Share-based Compensation was $143670.0 (2025), whereas its average is $142288.2.
  • Examining YoY changes over the last 5 years, Bioadaptives' Share-based Compensation showed a top increase of 7552.13% in 2021 and a maximum decrease of 7552.13% in 2021.
  • Bioadaptives' Share-based Compensation (Quarter) stood at $163900.0 in 2021, then increased by 27.44% to $208871.0 in 2024, then plummeted by 49.73% to $105000.0 in 2025.
  • Its last three reported values are $105000.0 in Q3 2025, $143670.0 for Q2 2025, and $90000.0 during Q1 2025.